Contact
Novartis Pharma NV/SA:
+ 32 (0)2 246 16 11
In case of an adverse event:
[email protected]
Phone number 24/h:
Bel: 0800 94 368
Lux: + 32 475 319 792
Image
ELN 2025 guidelines
Apperley, J.F. et al. Leukemia 39,1797-1813 (2025). Under creative commons license CC-BY (Deed - Attribution 4.0 International - Creative Commons)
For HCPs